Implitapide (AEGR 427) |
Catalog No.GC33766 |
L'implitapide (AEGR 427) (AEGR 427) est un inhibiteur microsomique de la protéine de transfert des triglycérides (MTP).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 177469-96-4
Sample solution is provided at 25 µL, 10mM.
Implitapide (AEGR 427) is a microsomal triglyceride transfer protein (MTP) inhibitor.
Implitapide suppresses MTP activity using a recombinant human form complexed with protein disulphide isomerase (IC50=10 nM) and inhibit secretion of apoB-containing very low-density lipoprotein (VLDL)-like lipoproteins from a human hepatoma cell (HepG2) with an IC50 value of 1.1 nM[1].
Implitapide (3.2 mg/kg/d) significantly reduces the plasma lipid levels to nearly or below the chow diet (CD) level at 4 and 8 weeks of treatment (p
[1]. Ueshima K, et al. Implitapide, a microsomal triglyceride transfer protein inhibitor, reduces progression of atherosclerosis in apolipoprotein E knockout mice fed a Western-type diet: involvement of the inhibition of postprandial triglyceride elevation. Biol Pharm Bull. 2005 Feb;28(2):247-52.
Average Rating: 5
(Based on Reviews and 4 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *